Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery.
Tor Henrik A TvedtEgil SteienBente ØvrebøRune HaaverstadWilliam HobbsMarek WardȩckiGeir Erland TjønnfjordSigbjørn Andreas BerentsenPublished in: American journal of hematology (2021)